Andrew M. Anisfeld

机构：Pfizer (United States)

发表论文 11 篇 · 总被引 2031 次 · h-index 9

代表论文

• Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor (2002 · Journal of Biological Chemistry · 被引 916)
• A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR (2003 · Molecular Cell · 被引 391)
• BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis (2002 · Journal of Lipid Research · 被引 386)
• Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors (2002 · Journal of Lipid Research · 被引 127)
• Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor (2003 · Journal of Biological Chemistry · 被引 87)
• CTP:phosphocholine cytidylyltransferase, a new sterol- and SREBP-responsive gene (2001 · Journal of Lipid Research · 被引 51)